Author:
Talker Leeran,Neville Daniel,Wiffen Laura,Selim Ahmed B.,Haines Matthew,Carter Julian C.,Broomfield Henry,Lim Rui Hen,Lambert Gabriel,Winter Jonathon,Gribbin Andrew,Chauhan Milan,De Vos Ruth,Kalra Paul,Begum Selina,Robinson Barbara,Mundy Bernadette,Rutter Heather,Madronal Karen,Weiss Scott T.,Hayward Gail,Brown Thomas,Chauhan Anoop,Patel Ameera X.,
Abstract
Abstract
Background
Although currently most widely used in mechanical ventilation and cardiopulmonary resuscitation, features of the carbon dioxide (CO2) waveform produced through capnometry have been shown to correlate with V/Q mismatch, dead space volume, type of breathing pattern, and small airway obstruction. This study applied feature engineering and machine learning techniques to capnography data collected by the N-Tidal™ device across four clinical studies to build a classifier that could distinguish CO2 recordings (capnograms) of patients with COPD from those without COPD.
Methods
Capnography data from four longitudinal observational studies (CBRS, GBRS, CBRS2 and ABRS) was analysed from 295 patients, generating a total of 88,186 capnograms. CO2 sensor data was processed using TidalSense’s regulated cloud platform, performing real-time geometric analysis on CO2 waveforms to generate 82 physiologic features per capnogram. These features were used to train machine learning classifiers to discriminate COPD from ‘non-COPD’ (a group that included healthy participants and those with other cardiorespiratory conditions); model performance was validated on independent test sets.
Results
The best machine learning model (XGBoost) performance provided a class-balanced AUROC of 0.985 ± 0.013, positive predictive value (PPV) of 0.914 ± 0.039 and sensitivity of 0.915 ± 0.066 for a diagnosis of COPD. The waveform features that are most important for driving classification are related to the alpha angle and expiratory plateau regions. These features correlated with spirometry readings, supporting their proposed properties as markers of COPD.
Conclusion
The N-Tidal™ device can be used to accurately diagnose COPD in near-real-time, lending support to future use in a clinical setting.
Trial registration: Please see NCT03615365, NCT02814253, NCT04504838 and NCT03356288.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Organization WH. The top 10 causes of death. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 12 May 2022.
2. Lancet T. Global burden of disease: GBD cause and risk summaries. https://www.thelancet.com/gbd/summaries. Accessed 23 May 2022.
3. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–89.
4. Hangaard S, Helle T, Nielsen C, Hejlesen OK. Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med. 2017;129:63–84.
5. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633–8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献